Results 1 to 10 of about 6,070 (154)
Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
Frontiers in Immunology, 2022 Recurrent vulvovaginal candidiasis (RVVC) and vulvovaginal candidiasis (RVVC) are one of the most common gynecological infections, primarily caused by Candida species. Although risk factors of RVVC and VVC have been identified in many studies, antifungal
Zhiya Yang
exaly +5 more sources
Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis
SAGE Open Medicine, 2022 Vulvovaginal candidiasis is a common infection associated most often with the overgrowth of the fungal species Candida albicans . Although most women will have at least one episode of vulvovaginal candidiasis in their lifetime, some will experience ...
Mark Martens
exaly +2 more sources
Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
Journal of Investigative Medicine High Impact Case Reports, 2022 Recurrent vulvovaginal candidiasis is a common disorder which causes significant morbidity among women worldwide, and treatment options are limited.
Leah M. Grant MD, Robert Orenstein DO
doaj +1 more source
Majalah Obstetri dan Ginekologi, 2022 HIGHLIGHTS 1. Hormonal changes during pregnancy lead to the presence of vulvovaginal candidiasis. 2. Increased incidence of vulvovaginal candidiasis in different pregnancy trimesters were analyzed. 3.
Regina Martina Cilik +2 more
doaj +1 more source
Vulvovaginal Candidiasis [PDF]
Pharmacy Today, 2019 Vulvovaginal candidiasis is the second most common vaginal infection after bacterial vaginosis. It is caused by yeasts, the vast majority of which belong to the genus Candida. Vulvovaginal candidiasis affects as many as 75 % of women during their childbearing years and 40 % of them experience recurrences.
Jill C. Cash, Rhonda Arthur
+5 more sources
Risk factors for recurrent vulvovaginal candidiasis [PDF]
Vojnosanitetski Pregled, 2010 Background/Aim. Recurrent vulvovaginal candidiasis is relatively frequent condition, and may have serious health consequences, like chronic vulvovaginal pain syndrome. The aim of our study was to determine possible risk factors for recurrent vulvovaginal
Janković Slobodan +13 more
doaj +1 more source
Vulvovaginal candidiasis [PDF]
, 2020 Vulvovaginal candidiasis (VVC) is one of the most frequent infections of the female genital tract; 75% of women of reproductive age will have one episode, and 5% of these will have recurring episodes (>3 a year). Symptoms can be quite unpleasant and impact the quality of life.
LInhares, Iara +3 more
+4 more sources
Frequency and Etiology of Vulvovaginal Candidiasis in Women Referred to a Gynecological Center in Babol, lran [PDF]
International Journal of Fertility and Sterility, 2009 Background Vulvovaginal candidiasis is the most common fungal disease in sexually active women of which Candida albicans is the primary etiologic agent. Materials and methods This cross-sectional study was performed to determine the etiologic agents of
Seddigheh Esmaeilzadeh +2 more
doaj +1 more source
Vulvovaginal Candidiasis in Pregnant Women and its Importance for Candida Colonization of Newborns
Folia Medica, 2016 Vulvovaginal candidiasis is the second most common cause of vaginitis worldwide (after bacterial candidiasis). Maternal vulvovaginal candidiasis is a major risk factor for Candida colonization and infection of the infant where prognosis depends on ...
Zisova Liliya G. +8 more
doaj +1 more source
Dapagliflozin-Induced Vulvovaginitis in an Atopic Patient with Type 2 Diabetes Mellitus
Endocrinology Research and Practice, 2018 Dapagliflozin, an oral anti-diabetic agent, is a recently discovered sodium-glucose co-transporter receptor-2 inhibitor, which improves glycemic control by facilitating the renal excretion of glucose.
Narin NASIROĞLU İMGA +2 more
doaj +1 more source